Jose L. Lopez-Ribot

Department of Biology, University of Texas San Antonio - UTSA

Affiliated withUniversity of Texas San Antonio - UTSA University of Texas at San Antonio

Research Area

Biography

Jose L. Lopez-Ribot has not added Biography.
If you are Jose L. Lopez-Ribot and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 105	2010
Publication title Cited by 9	2012

Other Publications

Article	Year
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrobial agents and chemotherapy\| PubMed ID: 12019078	2002
In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. Journal of clinical microbiology\| PubMed ID: 12037093	2002
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. The Journal of antimicrobial chemotherapy\| PubMed ID: 12039889	2002
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. Journal of clinical microbiology\| PubMed ID: 12202543	2002
The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS microbiology letters\| PubMed ID: 12204378	2002
In vitro activity of caspofungin against Candida albicans biofilms. Antimicrobial agents and chemotherapy\| PubMed ID: 12384370	2002
In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrobial agents and chemotherapy\| PubMed ID: 12384379	2002
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Applied and environmental microbiology\| PubMed ID: 12406738	2002
Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryotic cell\| PubMed ID: 14555488	2003
Antifungal combinations against Candida albicans biofilms in vitro. Antimicrobial agents and chemotherapy\| PubMed ID: 14576141	2003
Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. The Journal of antimicrobial chemotherapy\| PubMed ID: 14657086	2004
The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis. FEMS microbiology letters\| PubMed ID: 15033231	2004
Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive C... Antimicrobial agents and chemotherapy\| PubMed ID: 15047549	2004
Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryotic cell\| PubMed ID: 15189992	2004
Antibody response to Candida albicans cell wall antigens. FEMS immunology and medical microbiology\| PubMed ID: 15196567	2004
Denture stomatitis: a role for Candida biofilms. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics\| PubMed ID: 15243471	2004
Candida biofilms: an update. Eukaryotic cell\| PubMed ID: 15821123	2005
Candida albicans biofilms: more than filamentation. Current biology : CB\| PubMed ID: 15964263	2005
A role for Efg1p in Candida albicans interactions with extracellular matrices. FEMS microbiology letters\| PubMed ID: 16487333	2006
Use of genome information for the study of the pathogenesis of fungal infections and the development of diagnostic tools. Revista iberoamericana de micologÃa : Ã³rgano de la AsociaciÃ³n EspaÃ±ola de Especialistas en MicologÃa\| PubMed ID: 16499417	2005
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. The Journal of infectious diseases\| PubMed ID: 16518764	2006
Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics\| PubMed ID: 17001605	2006
Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrobial agents and chemotherapy\| PubMed ID: 17005810	2006
Biofilm formation by Candida albicans mutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain. FEMS yeast research\| PubMed ID: 17042757	2006
A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics\| PubMed ID: 17051645	2006
Proteomics to study Candida albicans biology and pathogenicity. Infectious disorders drug targets\| PubMed ID: 17168799	2006
Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia\| PubMed ID: 17909983	2007
Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infection and immunity\| PubMed ID: 17967861	2008
UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Molecular biology of the cell\| PubMed ID: 18216277	2008
A seed and feed model for the formation of Candida albicans biofilms under flow conditions using an improved modified Robbins device. Revista iberoamericana de micologÃa : Ã³rgano de la AsociaciÃ³n EspaÃ±ola de Especialistas en MicologÃa\| PubMed ID: 18338926	2008
Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infection and immunity\| PubMed ID: 18573891	2008
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nature protocols\| PubMed ID: 18772877	2008
Effect of tunicamycin on Candida albicans biofilm formation and maintenance. The Journal of antimicrobial chemotherapy\| PubMed ID: 19098294	2009
Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19116272	2009
Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis. Clinical and vaccine immunology : CVI\| PubMed ID: 19144791	2009
Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance. Mycopathologia\| PubMed ID: 19370400	2009
Adhesion of Candida albicans to endothelial cells under physiological conditions of flow. Infection and immunity\| PubMed ID: 19581400	2009
Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. The Journal of antimicrobial chemotherapy\| PubMed ID: 19584104	2009
Characteristics of Candida albicans biofilms grown in a synthetic urine medium. Journal of clinical microbiology\| PubMed ID: 19794044	2009
Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia\| PubMed ID: 20012895	2010
Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS pathogens\| PubMed ID: 20360962	2010
The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryotic cell\| PubMed ID: 20709787	2010
An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow. Virulence\| PubMed ID: 21178492	2010
Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrobial agents and chemotherapy\| PubMed ID: 21518839	2011
Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease. PloS one\| PubMed ID: 21633704	2011
Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses\| PubMed ID: 21668524	2012
Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS pathogens\| PubMed ID: 21931556	2011
Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis. Journal of basic microbiology\| PubMed ID: 22052380	2011
Sodium hypochlorite, chlorhexidine gluconate, and commercial denture cleansers as disinfecting agents against Candida albicans: An in vitro comparison study. General dentistry\| PubMed ID: 22313927	2011